Compared with the high dose of ZGGS15, the high dose of ZGGS15 plus anti-PD-1 antibody (5 mg/kg + 1 mg/kg) could significantly inhibit tumor growth (p < 0.05). Here, PDCD1 is linked to neoplasm.